This summary is generated by an algorithm. If you find any mistakes, let us know.

Bioinformatics Biotechnology Genetics North America

Phase Genomics to Develop Commercial Platform for the Discovery of New Viruses with $1.7 Million Grant

– Phase Genomics, Inc. announced the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID).
– This funding will fuel the commercialization of a first-in-class solution for the discovery of DNA viruses, employing a novel reagent kit and robust software platform that leverages Phase Genomics’ proprietary Hi-C technology.
Phase Genomics is also funded by revenue from sales of its proximity ligation (Hi-C) kits, scientific services, and computational analysis.

Source
Crunchbase icon

Content report

The following text will be sent to our editors: